Urinary aHGF, IGFBP3 and OPN as diagnostic and prognostic biomarkers for prostate cancer

Author： Prager Alisa J   Peng Cynthia R   Lita Elena   McNally Debbie   Kaushal Aradhana   Sproull Mary   Compton Kathryn   Dahut William L   Figg William D   Citrin Deborah   Camphausen Kevin A  

Publisher： Future Medicine

ISSN： 1752-0363

Source： Biomarkers in Medicine, Vol.7, Iss.6, 2013-12, pp. : 831-841

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The combined serum levels of miR‐375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 6, 2015-09 ,pp. : 1406-1416

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel diagnostic and prognostic biomarkers in esophageal cancer

By Plum Patrick S   Bollschweiler Elfriede   Hölscher Arnulf H   Warnecke-Eberz Ute  

Expert Opinion on Medical Diagnostics, Vol. 7, Iss. 6, 2013-11 ,pp. : 557-571

Informa Healthcare

Access to resources Recommend Favorite

Novel diagnostic and prognostic biomarkers in biliary tract cancer

By Skipworth James RA   Timms John F   Pereira Stephen P  

Expert Opinion on Medical Diagnostics, Vol. 7, Iss. 5, 2013-09 ,pp. : 487-499

Informa Healthcare

Access to resources Recommend Favorite

Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer

By  

THE PROSTATE, Vol. 75, Iss. 5, 2015-04 ,pp. : 539-549

John Wiley & Sons Inc

Access to resources Recommend Favorite

DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer

By Gyparaki Melina-Theoni   Basdra Efthimia   Papavassiliou Athanasios  

Journal of Molecular Medicine, Vol. 91, Iss. 11, 2013-11 ,pp. : 1249-1256

Springer Publishing Company

Access to resources Recommend Favorite